<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01918618</url>
  </required_header>
  <id_info>
    <org_study_id>EA1-044-13</org_study_id>
    <nct_id>NCT01918618</nct_id>
  </id_info>
  <brief_title>Renal Effects of Levosimendan in Cardiac Surgery Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <brief_summary>
    <textblock>
      Recent experimental and clinical data suggest a benefit of levosimendan on the kidney
      function. Therefore, this retrospective, single center, matched-pairs analysis aimed to
      investigate whether administration of levosimendan was associated with improved renal
      function in cardiac surgery patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of plasma creatinine (Difference in renal function)</measure>
    <time_frame>last available value pre-op (baseline), first available value on post-op day 1, 2, 3 and 4</time_frame>
    <description>Only in patients not requiring renal replacement therapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of urine output after surgery (difference in renal function)</measure>
    <time_frame>post-op day 1, 2, 3, 4</time_frame>
    <description>Only in patients not requiring renal replacement therapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cumulative incidence and duration of hemodialysis (Difference in renal function)</measure>
    <time_frame>last day of hospital stay</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative Length of stay (hospital and ICU)</measure>
    <time_frame>last day of hospital stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>last day of hospital stay</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">92</enrollment>
  <condition>Treatment of Left Heart Insufficiency in an Operative Setting of Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Levosimendan</arm_group_label>
    <description>study group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Levosimendan</arm_group_label>
    <description>Control group</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing cardiac surgery between 2007 and 2011 followed by postoperative
        observation on an ICU of the anaesthesiology department of the Charité hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing cardiac surgery (OPS 5-35 bis 5-37) between 2007 and 2011 followed
             by postoperative observation on an ICU of the anaesthesiology department of the
             Charité hospital

        Exclusion Criteria:

          -  Patients younger 18

          -  Preexisting renal insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Charité - University Medicine Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.</citation>
    <PMID>17331245</PMID>
  </reference>
  <reference>
    <citation>Yakut N, Yasa H, Bahriye Lafci B, Ortac R, Tulukoglu E, Aksun M, Ozbek C, Gurbuz A. The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study. Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):235-9. Epub 2007 Dec 3.</citation>
    <PMID>18056154</PMID>
  </reference>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2013</study_first_submitted>
  <study_first_submitted_qc>August 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2013</study_first_posted>
  <last_update_submitted>August 6, 2013</last_update_submitted>
  <last_update_submitted_qc>August 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Jan Braun, MD</investigator_full_name>
    <investigator_title>PD Dr. med.</investigator_title>
  </responsible_party>
  <keyword>levosimendan</keyword>
  <keyword>renal effects</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>left heart insufficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simendan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

